Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 519.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 136.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 376.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -101.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 235.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 93.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 352.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -78.00 |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | 3,470.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,470.00 |
| Dec 31, 2025 | 3,230.00 |
| Sep 30, 2025 | 3,182.00 |
| Jun 30, 2025 | 1,583.00 |
| Mar 31, 2025 | 4,972.00 |
| Dec 31, 2024 | -2,015.00 |
| Sep 30, 2024 | 5,427.00 |
| Jun 30, 2024 | 29,619.00 |
| Mar 31, 2024 | 3,124.00 |
| Dec 31, 2023 | 7,733.00 |
| Sep 30, 2023 | 1,631.00 |
| Jun 30, 2023 | -20,207.00 |
| Mar 31, 2023 | 6,476.00 |
| Dec 31, 2022 | 9,140.00 |
| Sep 30, 2022 | 4,773.00 |
| Jun 30, 2022 | 899.00 |
| Mar 31, 2022 | -5,592.00 |
| Dec 31, 2021 | -1,583.00 |
| Sep 30, 2021 | -184.00 |
| Jun 30, 2021 | 4,661.00 |